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Deletions of the short arm of chromosome 9 are associated with
two distinct clinical entities. Small telomeric 9p24.3 deletions
cause genital anomalies in male subjects, ranging from disorder
of gonadal sex to genital differentiation anomalies, while large
terminal or interstitial deletions result in 9p-malformation
syndrome phenotype. The critical region for non-syndromic
46,XY sex reversal was assigned to a 1Mb interval of chromo-
some 9p, extending from the telomere to the DMRT genes
cluster. The 9p-syndrome was assigned to bands 9p22.3p24.1,
but aphenotypicmaphasnotbeenestablished for this condition,
probably because of the lack of detailed molecular and/or phe-
notypic characterization, as well as frequent involvement of
additional chromosome rearrangements. Here, we describe a
unique patient with a small isolated 9p terminal deletion, char-
acterized by array-CGH and FISH, who shows a complex phe-
notype with multiple physical anomalies, resembling the 9p-
syndrome, disorder of sex development with gonadoblastoma,
congenital heart defect and epilepsy. The observed deletion
includes the 46,XY sex-reversal critical region, excluding the
region so far associated with the 9p-syndrome. Genotype–
phenotype correlations are tentatively established comparing
our patient to seven other previously reported males with iso-
lated terminal 9p deletions, finely defined at a molecular level.
Our observations expand the 9p deletion clinical spectrum, and
add significantly to the definition of a 9p-syndrome critical
region.  2012 Wiley Periodicals, Inc.
Key words: chromosome 9p deletion; 9p deletion syndrome;
trigonocephaly; congenital heart defect; gonadal dysgenesis; gona-
doblastoma; ambiguous genitalia; XY sex reversal; epilepsy
INTRODUCTION
Since thefirst report byAlfi et al. [1973]over 180 cases of 9pdeletion
(9p-) syndrome have been described. This syndrome represents a
clinically variable and genetically heterogeneous condition, with a
wide spectrum of phenotypic manifestations and variable size of
causal deletions.
The main clinical findings are intellectual disability, congenital
hypotonia and a range of cranio-facial abnormalities, such as
trigonocephaly, prominent forehead, flat occiput, epicanthic folds,
small palpebral fissures, arching eyebrows, hypertelorism, midface
hypoplasia with short nose, depressed nasal bridge, anteverted
nostrils, thin upper lip vermilion, long philtrum, microstomia,
micrognathia, malpositioned and missing teeth, short neck with a
low posterior hairline, low-set, malformed, and posteriorly angu-
lated ears [Young et al., 1982; Huret et al., 1988; Hou, 2003].
Although less frequently, other anomalies, involving multiple
organs, have been observed in patients with 9p deletions [Shashi
et al., 1998; Muroya et al., 2000; Hauge et al., 2008], that is, cardiac
defects, epilepsy, inguinal hernia, omphalocele, choanal atresia,
scoliosis, non-ketotic hypoglycemia.
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Deletions of the terminal portion of 9p are associated in males
with genital anomalies which can vary significantly from disorders
of gonadal sex (i.e., gonadal dysgenesis or the presence of an
ovotestis) to disorders of genital differentiation (i.e., cryptorchid-
ism and/or hypospadias) [Muroya et al., 2000; Ogata et al., 2001;
Fujimoto et al., 2004].
The deletion breakpoints cluster in bands 9p22-p24 and inmost
patients additional rearrangements have been identified involving
other chromosomes. No clear-cut genotype–phenotype correla-
tions have been established.
In general, telomeric deletions cause gonadal dysgenesis, while
more proximal, interstitial deletions result in the malformation
syndrome outlined above. The respective consensus regions (CRs)
are reportedly located at 9p24.3, extending from the DMRT genes
(included) to the telomere, and at 9p22.3-p24.1 [Flejter et al., 1998;
Guioli et al., 1998; Christ et al., 1999; Raymond et al., 1999; Calvari
et al., 2000; Kawara et al., 2006; Faas et al., 2007; Swinkels et al.,
2008].
Except for a single case of sex reversal that was associated
to a telomeric deletion not including the DMRT genes, in
all previously described cases the deletion included the
three DMRT genes (DMRT1, DMRT3, and DMRT2) [Calvari
et al., 2000].
We describe a unique patient where a small terminal 9p deletion
is associated with a complex phenotype, consisting of multiple
physical anomalies, resembling the 9p-malformation syndrome,
disorder of sex development with gonadoblastoma, congenital
heart defect, and epilepsy.
CLINICAL REPORT AND GENETIC TESTS
The patient was the fourth child of non-consanguineous parents of
Caucasian ethnicity. The older siblings are healthy. Pregnancy and
delivery were reportedly uneventful. The childwas born at 41weeks
gestation by spontaneous vaginal delivery. Birth weight was 4,500 g
(þ2.4 Z-score SD), length 56 cm (þ2.4 Z-score SD), cranial cir-
cumference 38 cm (þ2.4 Z-score SD), and Apgar scores were 9 and
10 at 1 and 5min, respectively. At birth a female sex was assigned,
based on the aspect of external genitalia.
In the seconddayof life a cardiacmurmurwasdetected. ECGand
cardiac ultrasound showed patent ductus arteriosus, bicuspid
aortic valve, and severe hypoplasia of the aortic arch, which
required surgical correction.
At 1 month of age the family pediatrician recognized genital
ambiguity, as well as craniofacial anomalies, leading to genetic and
hormonal investigations. Chromosomes were apparently normal
male (46,XY) and FISH analysis confirmed the presence of the SRY
gene. Androgen insensitivity and 5alpha-reductase deficiency were
ruled out by hormonal tests (basal serum testosterone 2.33 ng/ml
and DHEAS 0.48 ng/ml).
At the age of 3 months the baby presented apneic spells and
generalized hypertonicity. Brain ultrasound and EEG showed no
anomalies, and the pediatric neurologist did not prescribe any
therapy. At 8 months, after the occurrence of additional apneic
episodes associated with cyanosis and generalized hypertonicity
lasting 30–60 sec, the patient was referred to us for further
investigations.
The growth was normal for the age, at physical examination,
several dysmorphic features were noted: hirsute forehead with
prominence of the metopic suture, apparent hypertelorism, epi-
canthic folds, short and upslanting palpebral fissures, short and
bulbous nose, microstomia with a high palate, flat and long
philtrum, micrognathia, and short neck. The hands were normal
with a mild degree of interdigital webbing. Neurological examina-
tion showed normal motor development and mild global devel-
opmental delay.
External genitalia showed significant ambiguity. Labio-scrotal
swellings were symmetrical; a perineal hypospadias with partial
peno-scrotal inversion was present, even though the phallus was
well developed, in length and girth (Fig. 1A). A palpable gonad was
present in the right inguinal region. A pelvic ultrasound confirmed
the presence of a gonad in the right inguinal canal, whereas no
gonad was detected on the left side. Hormonal analysis (FSH,
LH, 17-OH-progesterone, dehydroepiandrosterone sulphate and
FIG. 1. Genital phenotype and laparoscopic view of the pelvis. A: Perineal hypospadias with partial peno-scrotal inversion. The arrow indicates the tiny
vaginal opening, not clearly visible in the picture. B: The small uterus is indicated by an asterisk.
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anti-M€ullerian hormone) showed normal values. A short hCG test
(5,000UI/m2 i.m.) was also normal.
Cardiac ultrasound showed good functional correction of the
congenital defect.
During hospitalization, the infant presented daily paroxysmal
episodesof brief generalized tonic spasmswith lossof consciousness
and cyanosis, organized in clusters.
Although cerebral ultrasound, awake and sleep EEG and brain
MRI were normal, antiepileptic therapy with phenobarbital was
started, with prompt seizures control.
Array-CGH performed on genomic DNA using Agilent oligo-
nucleotide array (Human Genome CGH microarray 4 44k; Agi-
lent Technologies, Santa Clara, CA) following the manufacturer
instructions, showed a small distal deletion of the short arm of
chromosome 9 of 6.5Mb in size, described as: arr 9p24.3p24.1
(204,367-6,582,172)x1 (probe alignments were referred to the
human March 2006, hg 18, genomic assembly). This deletion,
molecularly ascertained, can be defined cytogenetically as 46,XY,
del(9)(p24.1), was confirmed by FISH analysis with a probe specific
for 9p telomere on metaphase chromosomes (ToTelVysion,
Vysis, Abbott, IL), which showed a single fluorescent signal on
9p telomere.
Basedon thesefindings, doctors and family decidedonamale sex
assignment and a correction of abnormal genitalia was planned.
At laparoscopy, a small uterus was found (Fig. 1B). On the left
side there was a tiny linear gonad, connected to the uterus by a
tubular structure resembling a fallopian tube devoid of fimbriae.
On the right side, a round grayish gonad was found with a smooth
surface, which was attached to a vas deferens. The uterus, the small
vagina and the left gonad were resected en bloc.
The first stage of the urethroplasty was then undertaken by
correcting the penile curvature and creating a neo-urethral plate
with a graft from the foreskin. Standard orchidopexy and peno-
scrotal transposition completed the surgical procedure. On histo-
logcal examination, the left mass was constituted by a neoplastic
nodule of 11mm in diameter, developing within a streak gonad.
The biopsy of the other gonad showed testicular tissue. The neo-
plasia was composed by a collection of cellular nests surrounded by
connective tissue stroma. The nests were solid, small, of oval or
round shape, and contained a mixture of germ cells and sex cord
derivates resembling immature Sertoli and granulosa cells,
respectively.
The associated gonadal tissue was constituted by fibrous tissue.
Thehistologicalpicturewas that of gonadoblastomadeveloping in a
streak gonad, whose nature could not be determined.
DISCUSSION
A host of reported deletions of various sizes map CRs on the short
arm of chromosome 9, related to two distinct clinical entities. A
non-syndromic form of 46,XY sex reversal maps to band 9p24.3 at
the extremity of chromosome 9p. The 9p-malformation syndrome
maps more proximally, in an interval corresponding to band
9p22.3p24.1. Genital anomalies ranging from cryptorchidism
and/or hypospadias to complete sex reversal can be found in 9p-
syndrome males, carriers of large terminal deletions encompassing
both CRs [Christ et al., 1999].
The sex reversal CR has been assigned to a 1Mb interval,
extending from the telomere to the DMRT genes [Flejter et al.,
1998; Guioli et al., 1998; Raymond et al., 1999]. Although all three
DMRT genes in this region show sequence similarity among
themselves and with Drosophila melanogaster and Caenorhabditis
elegans sexual regulators doublesex and mab-3, respectively,
DMRT1 is the strongest candidate gene for sex reversal
[Raymond et al., 1999; Ottolenghi and McElreavey, 2000]. In
humans, DMRT1 is highly expressed in the genital ridge during
male sexual differentiation and to the testes in adults. Functional
studies in mice showed that Dmrt1 plays a key role in postnatal
testicular differentiation and maintenance [Raymond et al., 2000;
Krentz et al., 2009; Matson et al., 2011]. An apparent exception is
represented by the case of two 46,XY siblings with sex reversal,
carriers of a small 9p terminal deletion, spanning about 700 kb and
excluding the DMRT gene cluster.
However, the proximal breakpoint was mapped in close prox-
imity of the 50 end of DMRT1, possibly causing a disruption of a
regulatory sequence and perturbing its expression [Calvari et al.,
2000].
Several attempts weremade over the last years to precisely define
a CR for the 9p-syndrome. Christ et al. [1999] assigned the CR to a
8Mb segment betweenD9S286andD9S285markers in 9p22p24, by
comparing 24 patients with 9p terminal deletions and one
[Wagstaff and Hemann, 1995] with an interstitial deletion, arising
from a paternal balanced complex rearrangement between chro-
mosomes 3, 8, and 9. This region was further restricted to a 4.7Mb
interval, spanning from RP11-933C16 to D9S285 in 9p22.3p23, by
Kawara et al. [2006] who described a 2-year-old boy with classical
9p-syndrome phenotype, bearing a complex chromosome rear-
rangementwith seven breakpoints involving chromosomes 2 and 9.
Subsequently, Faas et al. [2007] narrowed down the extent of this
commonly deleted 9p region defining a smallest region of overlap
(SRO) of 3.5Mb, betweenRP11-33C16 andRP11-725C9probes, in
a patient with a dup/del 9p anomaly.
Finally, genotype–phenotype correlations in 13 deleted patients
with and without trigonocephaly, led Swinkels et al. [2008] to
further restrict the 9p-syndromeCR to an interval of 300 Kb, falling
outside the SRO proposed by Faas et al. [2007] and flanked by
RP11-271B19 and RP11-392B02 markers (Fig. 2).
Overall, the proposed regions do not explain a series of reported
cases bearing small terminal deletions, whose clinical presentation
is compatiblewith the 9p-malformation syndrome (see below), and
complicate genotype–phenotype correlations. Furthermore, the
lack of detailed molecular and/or phenotypic characterization of
themajority of reported cases, aswell as the possible contribution of
other chromosomes involved in complex rearrangements, add
complexity to the definition of a phenotypic map.
In an attempt to add some clarity to a rather confused issue, we
compared our patient with clinical features of sevenreported 46,XY
patients, carriers of isolated 9p terminal deletions, finely charac-
terized by MLPA, microsatellite typing, FISH and array-CGH
(Fig. 2 and Table I).
Of these seven patients, at least 3 (Cases 1–3 in Fig. 2 andTable I)
havedeletions that donot correspond to anyof theCRsproposed so
far, in spite of having some clinical features resembling the 9p-
phenotype. One patient had a 1.2Mb deletion associated with
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intellectual disability, distinctive facial appearance, andmild prom-
inence of the metopic suture [Hauge et al., 2008]. Another patient
with a 7Mb terminal deletion presented with intellectual disability,
behavior problems, and gonadal dysgenesis [Vinci et al., 2007]. A
phenotype with gonadal dysgenesis, learning difficulties and affec-
tive disorder was also described in a subject with a small terminal
deletion of about 3Mb [Veitia et al., 1998].
Our patient presented with complex abnormalities of genitalia,
including a congenital gonadoblastoma, associated with facial
features typical of the 9p-syndrome. He did not have frank trig-
onocephaly, but rather a prominent forehead, as described inmany
other cases of this syndrome [Ogata et al., 2001; Barbaro et al.,
2009].
There are only a small number of patients with 9p-syndrome in
whomgonads have been examined indetail. A gonadoblastomawas
reported in only four patients with 9p-syndrome and sex reversal
[Huret et al., 1988; Mc Donald et al., 1997; Muroya et al., 2000;
Livadas et al., 2003], leading to hypothesize the existence of a
gonadoblastoma suppressor gene in the distal portion of chromo-
some 9p.
The present report is the first description of a 9p deletion in a
patient with a complex phenotype, including neurological findings,
features of the 9p-malformation syndrome, sex reversal, and gona-
dal dysgenesis with gonadoblastoma.
The neurological findings consisted ofmild developmental delay
and epileptic seizures. Almost all previously described cases pre-
sented developmental delay of variable severity, particularly behav-
ior problems, language impairment, or learning difficulties. These
aspects are difficult tomeasure precisely in our patient, considering
his very young age.
Epilepsy consisted of generalized tonic seizures in clusters.
Unfortunately, we could not perform an ictal EEG, so that a focal
onset cannot be excluded. Even thoughwe did not find paroxysmal
discharges in wakefulness and sleep interictal EEG, seizure semei-
ology and prompt response to phenobarbital confirmed their
epileptic nature. It should be noted that seizure disorder with
normal interictal EEG is not uncommon, occurring for instance
in benign familial and non-familial infantile seizures [Caraballo
et al., 2003].
Epileptic seizures are rarely reported in patients with 9p deletion
syndrome. In Case 1 of Hauge et al. [2008] there was a clinical
history of suspected seizures, not supported by EEG studies, while
Case 8 presented febrile seizure at 2 years followed by a variant of
Landau–Kleffner syndrome. The authors suggested that the
DOCK8 gene deletionmay play a role in seizures.DOCK8 is located
400 kb distal to the DMRT1 gene. It is involved in the reorgan-
izationof the actinfilament systemand is expressed inmanyorgans,
including heart and brain, although at low levels [Vinci et al., 2007].
FIG. 2. Schematic representation of the distal 16 Mb of the short arm of chromosome 9 from the telomere to 9p22.3 band. Bars from 1 to 8 indicate
molecular defined terminal deletions in seven previously reported patients (1–7) and in present case (8); dotted lines indicate a uncertain proximal
breakpoint definition. Bars (a) and (b–d) illustrate the critical region for sex reversal and for 9p-consensus phenotype, respectively.
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Our patient has a congenital heart defect that one could tentatively
relate to malfunction of DOCK8.
Based on evidence gathered from the study of this patient, we
propose that the region associated with the 9p-core phenotype lies
between chromosomebands 9p22 and9p24 as previously suggested
[Christ et al., 1999; Kawara et al., 2006; Faas et al., 2007; Swinkels
et al., 2008], and that atypical cases, where smaller terminal
deletions are associated with 9p-syndrome clinical features, may
result from the perturbation of proximally located gene(s), exerted
by the deletion of distal regulatory element(s).
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